Please ensure Javascript is enabled for purposes of website accessibility

Walgreen December Sales Rise 7%; Pharma Sales Strong

By Eric Volkman – Jan 6, 2014 at 6:47PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Walgreen has a good month, with overall pharmacy sales edging into double-digit growth territory.

Last year ended well for drugstore major Walgreen (WBA -0.73%), as its key operating metrics for December reveal. Total sales for the month amounted to $7.2 billion, or 7.2% higher on a year-over-year basis. Overall front-end (i.e., non-pharmacy goods) sales also rose, by 4% across the same time frame, while pharmacy sales increased by a robust 10.2%.

Comparable-store sales rose 6.1% on a year-over-year basis, while front-end "comps" advanced by 2.5% and pharmacy sales by 9%. Comparable-store customer traffic, however, saw a decline of 1.3%. 

Last month, Walgreen posted fiscal Q1 2014 results that saw year-over-year improvements in both the top and bottom line. Net sales were $18.3 billion while attributable net profit came in at $695 million ($0.72 per diluted share). Both figures were improvements over Q1 2013's figures of $17.3 billion and $413 million ($0.43), respectively.

Fool contributor Eric Volkman has no position in Walgreen. Nor does The Motley Fool. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Stocks Mentioned

Walgreens Boots Alliance Stock Quote
Walgreens Boots Alliance
WBA
$40.60 (-0.73%) $0.30

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.